Abstract During the last decade, the combination of rapid whole genome sequencing capabilities, application of genetic and computational tools, and establishment of model systems for the study of a range of species for a spectrum of biological questions has enhanced our cumulative knowledge of mycobacteria in terms of their growth properties and requirements. The adaption of the corynebacterial surrogate system has simplifi ed the study of cell wall biosynthetic machinery common to actinobacteria. Comparative genomics supported by experimentation reveals that superimposed on a common core of 'mycobacterial' gene set, pathogenic mycobacteria are endowed with multiple copies of several protein families that encode novel secretion and transport systems such as mce and esx; immunomodulators named PE/PPE proteins, and polyketide synthases for synthesis of complex lipids. The precise timing of expression, engagement and interactions involving one or more of these redundant proteins in their host environments likely play a role in the defi nition and differentiation of species and their disease phenotypes. Besides these, only a few species specifi c 'virulence' factors i.e., macromolecules have been discovered. Other subtleties may also arise from modifi cations of shared macromolecules. In contrast, to cope with the broad and changing growth conditions, their saprophytic relatives have larger genomes, in which the excess coding capacity is dedicated to transcriptional regulators, transporters for nutrients and toxic metabolites, biosynthesis of secondary metabolites and catabolic pathways. In this review, we present a sampling of the tools and techniques that are being implemented to tease apart aspects of physiology, phylogeny, ecology and pathology and illustrate the dominant genomic characteristics of representative species. The investigation of clinical isolates, natural disease states and discovery of new diagnostics, vaccines and drugs for existing and emerging mycobacterial diseases, particularly for multidrug resistant strains are the challenges in the coming decades.
Introduction and signifi cance
Whole genome sequencing of organisms has become a reality to the point that there is a growing interdependence between in silico predictions based on genomic codes and classical experimental approaches in everyday biological research for questions that span the grand description of the 'tree of life' to the simpler mechanism of a single enzymatic reaction. Already, vast amounts of genome and bioinformatic codes exist that beg to be harnessed. These resources are simultaneously overwhelming and unwieldy, yet necessary and desirable.
In this review we attempt to summarize the principles, methods and challenges that combine in silico resources, with biological tools in the understanding of genotypephenotype relationships in mycobacteriology. We address briefl y, a range of themes including ecology, epidemiology, and physiology. Furthermore, we present independent in silico comparative analyses of multiple sequenced genomes that summarize and delineate major genetic signatures and trends within and between mycobacterial genomes.
The objective of this review and analysis is to cite landmark studies and novel approaches to give the reader an overall appreciation of the major advances in the study and the understanding of mycobacteria that have been accelerated by availability of genome sequences. Although gaps remain, it is hoped that practical outcomes emerge from this information in due course, such as diagnostic kits, vaccine and drugs for different diseases.
Taxonomy of mycobacteria
The genus Mycobacterium is derived from the phylum Actinobacteria, class Actinobacteria, which includes gram-positive bacteria of high genomic G+C content. Further classifi cation (Table 1 ) based on 16sRNA sequences and morphological traits places the genus within subclass Actinobacteridae, order Actinomycetales, suborder Corynebacterineae, and family Mycobacteriaceae (http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/ wwwtax.cgi?mode=Root) [1, 2] .
Other families within suborder Corynebacterineae in this classifi cation include Corynebacteriaceae, Dietziaceae, Gordoniaceae, Nocardiaceacea and Tsukumurellaceae that share certain morphological and biochemical features with those of Mycobacteriacea. Literature also cites relationships of mycobacteria with distant genera of other suborders such as Streptomycineae (Streptomyces), Propionibacterineae (Proprionebacterium), Pseudonocardineae (Amycolatopsis), Micrococcineae (Cellulomonas and Micrococcus) (Table 1 )
Availability of microbial genome sequences within Actinomycetales
With regard to microbes, the National Center for Biotechnology Information (NCBI) reports 524 complete, 320 assembled, and 462 unfi nished genome sequencing projects (as of June 2007). Genome sequence information of Actinomycetales is abundant, with 146 submissions in the current database. These include complete and unfi nished genomes, and plasmid sequences. Moreover the suborder Corynebacterineae is extensively represented with 82 sequence projects, of which 26 are complete genomes (Table 1) .
Mycobacterium, a genus that contains species of signifi cant pathogenic import along with a number of nonpathogenic relatives is well represented in this genome-era, starting with the publication of the genome sequence of M. tuberculosis, the agent of human tuberculosis (TB) in 1998 [3] . Subsequently, sequences of M. bovis that causes TB in cattle and wildlife [4] and its attenuated vaccine strains M. bovis Pasteur [5] and BCG became known [6] . The other two sequenced human pathogens are M. leprae [7] , and M. ulcerans [8] that cause skin diseases, leprosy and Buruli ulcer, respectively. M. avium subsp. paratuberculosis [9] , the bacterial agent of cattle Johne's disease, is also implicated in human Crohn's disease.
The source for the taxonomy is http://www.ncbi.nlm.nih.gov/ Taxonomy/Browser/wwwtax.cgi?mode=Undef&name= Bacteria&lvl=3&srchmode=1&keep=1&unlock. The numbers after the names of the suborder and family in columns 1 and 2 respectively, refer to the number of completed sequencing projects. When there are two numbers, the fi rst refers to the total number of sequencing projects to date, and the second refers to the completed genome sequences. The presence of cell wall molecules trehalose monomycolate (TMM) and/or trehalose di mycolate (TDM), arabinogalactan (AG), lipomannan (LM) and/or lipoarabinomannan (LAM) and mycolic acids, is indicated by the + symbol. Truncated or shorter LAMs and mycolic acids as compared to those of mycobacteria are indicated by * and ** respectively. References for occurrence or characterization of cell wall associated molecules are included in the last column.
Genomics of mycobacteria
In an insightful essay in 2000, Weinstock [23] , predicting the pace of accumulation of microbial genome sequence data, proposed a 'top-down' genomics approach in modern microbiology. He noted that while potential and limitations exist in handling large raw datasets, experimental strategies that could turn these data into new knowledge about microbial processes, even in the absence of functional gene validations, are plausible. The gains in less than a decade, have already justifi ed 'genomics' as an independent means to study bacteria. Notable successes and future possibilities as exemplifi ed for mycobacteria are highlighted herein.
Genetic tools for mycobacteria
The development of temperature-sensitive plasmids [24] and mycobacteriophages [25] was key to launching a series of experiments allowing site specifi c and random mutagenesis of mycobacterial genomes including those of M. smegmatis, M. tuberculosis, M. bovis BCG, M. avium, and M. marinum, fostering the functional characterization of genes involved in nutrition, cell wall synthesis, infection, survival and persistence in various model systems. The test conditions examined growth properties in defi ned medium in vitro (liquid or solid bacteriological media and macrophage systems), or in vivo, in animal host models that include mouse, zebrafi sh, leopard frog, guinea pig, rabbit and monkey.
The systematic and impressive effort by Lamichhane et al. [26] , capitalizing on genome sequence availability of M. tuberculosis CDC1551 is noteworthy. By using the Himar1 phage to transpose randomly into the M. tuberculosis genome, picking individual surviving insertion clones, and identifying the point of insertion of the transposon in each by sequencing the fl anking genomic regions, they found that up to 65% of the predicted coding sequences (CDSs) could be interrupted, i.e., these CDSs were not 'lethal' (or 'non-essential') for growth on agar plates. The remaining 35% of CDSs not represented under the experimental growth conditions were therefore interpreted to be 'essential' for survival. Mutant clones from this experiment serve as a valuable source of defi ned gene knock outs for further phenotypic characterization [25] .
Array technologies accelerate screening of mycobacteria mutants
The earliest screens of mutant libraries were based on the construction of transposon vectors carrying an 'array of signature tags' in the insertion element [27, 28] . Pools of signature tagged mutants would then be used to infect mice. The genes required for 'growth in vivo' were identifi ed by comparing hybridization patterns and intensities of 'input' versus 'recovered' transposon DNA probes on a membrane format containing an array of signature tagged DNA sequences.
A frequently cited method in this regard is that by Sassetti et al. [29, 30, 31] , in which gene arrays were created to rapidly identify transposon interrupted genes by the method called TraSH (transposon site hybridization). An 'essential gene list' was compiled based on growth of M. tuberculosis H37Rv mutants on 7H10 agar containing OADC enrichment [30] . The major fi nding from this study was that most of the 614 essential M. tuberculosis genes are intact in the heavily degraded genome of M. leprae, while 'non-essential' M. tuberculosis genes have been deleted or mutated in M. leprae. Another conclusion was that one third of these essential genes are not found in other bacteria and have no assigned function, indicating that the core mycobacterial physiology requires genes beyond those in 'minimum genomes' of mycoplasmas [28] .
Mycobacterial phylogeny
There are many ways to classify and study mycobacteria for their genotype-phenotype associations. Growth rates separate them down into rapid or slow growers, habitat defi nes them as environmental (free living/saprophytic) or host adapted, while disease causing properties separate the tuberculous from the non-tuberculous mycobacteria (NTM) [32] . The terms atypical mycobacteria and mycobacteria other than M. tuberculosis (MOTT) are also in use for NTM that cause infections. The term M. tuberculosis complex mainly includes M. tuberculosis, M. microti, M. africanum and M. bovis.
Recognizing that there have been many diverse criteria and schemes for bacterial taxonomy since the late 1800s, and that the taxonomy based only on 16S rDNA sequences encoding rRNAs often confl icted with existing higher level taxonomy, taxonomists called for 'polyphasic' systematics, which required that phylogeny be determined by DNA sequences, and that more than one class of molecules be included [33] . Now that whole genome sequences are becoming available, it should be possible to perform genome wide comparisons to demonstrate phylogenetic relatedness of species (phylogenomics) and also yield insights into factors that govern niche adaptation and virulence. However, there are no simple, single methods that can accurately compile and represent all the genomic data due to the variability in the rates of evolution of different parts of the genome, recombination, gene loss and acquisition events. Genome trees are typically built from one of fi ve common sources of phylogenetic markers: sequence attributes such as word frequencies (alignment free techniques), shared gene content, gene order, average sequence similarity, and gene trees [34] .
Literature cites multilocus sequence typing (MLST) as a means for determining species and higher level phylogeny whereby a limited set of loci, such as those for housekeeping genes are compared by PCR and sequencing techniques.
• For the genus Mycobacterium comprising species with highly similar or identical 16S rRNA sequences, additional genes such as rpoB, gyrB, recA, hsp65, sodA and ITS, have been sequenced and compared to improve discrimination [35] .
• Devulder et al. [36] assembled a set of nearly 100 cultivable strains of Mycobacterium spp., amplifi ed and sequenced portions of the 16rRNA, hsp65, rpoB or sodA genes. Comparing fi ve phylogenetic trees, four computed from a single gene (16rRNA, hsp65, rpoB or sodA) and the fi fth, from concatenation of all four genes, the latter (MLST tree) was more robust than that computed from single genes. Furthermore, The source for the taxonomy is http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&id=2037&lvl=3&p=mapview&lin=f&keep=1&srchmode=1&unlock. The numbers after the names of the suborder and family in columns 1 and 2, respectively refer to the number of completed sequencing projects. When there are two numbers, the fi rst refers to the total number of sequencing projects to date and the second refers to the completed genome sequences. The presence of cell wall molecules trehalose monomycolate (TMM) and/or trehalose dimycolate (TDM), arabinogalactan (AG), lipomannan (LM) and/or lipoarabinomannan (LAM) and mycolic acids, is indicated by the + symbol. Truncated or shorter LAMs and mycolic acids as compared to those of mycobacteria are indicated by * and ** respectively. References for occurrence or characterization of cell wall associated molecules are included in the last column.
individual species except those of the M. tuberculosis complexes, were resolved and showed that the slowly growing species descended and separated from the rapid growers.
• Recent examples of evolutionary studies in mycobacteria include evidence for the descent of M. bovis from M. tuberculosis rather than in the reverse direction [37] ; the combined downsizing of the M. marinum genome and the acquisition of a plasmid bearing virulence gene clusters to generate a new species, M. ulcerans, a human host-adapted Mycobacterium sp. associated in the environment with the aquatic insect Naucoris cimicoides [38] and also snails [39] and plants [40. ] Similarly, strains within and outside the M. avium complex (MAC) have been studied to address evolution, strain differentiation, differential growth niches and replication rates [7, 32, 41] . Details for some such fi ndings are presented in later sections of this review.
Common and species-specifi c properties of Mycobacterium spp.
In previous reviews, we and others have proposed and demonstrated that M. leprae, a paradigm genome with highest levels of known reductive evolution, serves as a 'model minimal Myocbacterium' [5, 42] because it is characterized by physical features shared by members of Mycobacteriaceae and few outside this family, the most prominent being the mycolylarabinogalactan peptidoglycan (mAGP) cell wall complex and the presence of glycolipids/lipoglycansPIMs (phosphatidylinositol mannosides), LM and LAM built on the phosphatidyl inositol (PI) anchor. Furthermore, contained in its smaller genome is information for pathogenicity. In accordance with this principle, it is not surprising that the 'essential gene list' for growth in an animal model that was experimentally discovered using the drop out saturation mutagenesis techniques, coincides with the intact genome fraction of the genome of M. leprae; non-essential genes of M. tuberculosis being those that are present in more than one functional equivalent, or else those lost by reductive evolution in M. leprae [43] . Nonetheless, it is obvious that beyond the small number of 'essential genes', the biological properties of individual species [growth habitats, replication rates, pathogenicity (tissue tropism and pathology) etc.] are not identical to that of M. leprae. The genetic origins of these species differences are still not clear and it is hoped that clues can be found in the genomes. Therefore, we try to address the shared features of Mycobacterium as a genus and the species-specifi c differences.
To this end, we allude to genes and gene families discussed in the literature and also present simple comparative in silico analyses of 10 selected genomes. We used on-line resources in the public domain, and intuitive approaches to allow us to simultaneously compare multiple sequenced and annotated genomes to recognize the shared and distinct genomic content. In Table 2 We then compared the relative abundance and species distribution of genes that encode proteins belonging to conserved functional categories known as Clusters of Orthologous Group (COG) as conceived by Tatusov et al. [44] .
• In an article entitled "A genomic perspective on protein families", Tatusov et al. [44] defi ne orthologs as genes in different species that evolved from a common ancestral gene by speciation; by contrast, paralogs are genes related by duplication within a genome. In this scheme, a COG consists of individual orthologous genes or orthologous groups of parlaogs from three or more phylogenetic lineages, whereby each COG can be assumed to have evolved from an individual ancestral gene through a series of speciation and duplication events. The database of COGs attempts to represent a phylogenetic classifi cation of the proteins encoded in sequenced genomes.
We used the Integrated Microbial Genomes (IMG) data management system developed by the U.S. Department of Energy Joint Genome Institute (DOE JGI), version 2.2 at http://img.jgi.doe.gov. A summary of the genomes and their COGs is shown in Table 3 .
We searched for the COGs that are more abundant (≥1) in one query species when compared to those encoded in a select panel of nine other species. In addition, we listed the genes within each of the COGs (except for the family encoding the PE-PPE genes and mobile elements/insertion sequence elements) and identifi ed the genes that were unique to the query species in relation to the other nine species. These are presented in subsequent sections (Tables 4-6). A few of the COGs with skewed distribution amongst the species that we examined are shown in Fig. 3 .
We are aware that approximately one third of sequenced genomes contain genes that are not assigned to any COGs. Furthermore, certain COGs belong to categories whose functions are not known. Therefore COG abundance profi ling can miss a signifi cant proportion of genes that are important in biology. Nevertheless, the results generally substantiate experimental fi ndings.
Novel gene families in mycobacteria
PE and PPE family of proteins Since their discovery, studies have sought to fi nd and ascribe biological functions for these proteins that are thought to be enriched in mycobacteria [3, 45] . Owing to their overall similarity, yet sequence variability, members of these families are believed to be involved in the intracellular survival and antigenic variation [3] . The extracellular localization of several of these proteins does indicate the potential for antigen presentation. However, other biological activities have been discovered, such as a role in intracellular macrophage survival in M. marinum [46] . Only a few of the genes are 'essential' by the Lamichhane and Sassetti criteria [26, 30] .
• The Conserved Domain database (http://www.ncbi. nlm.nih.gov/Structure/cdd/wrpsb.cgi) [47, 48] describes and depicts these proteins and their domains as follows:
PE family: This family is named after a PE (Pro-Glu) motif found at the amino terminus of the domain (pfam00934) (Fig. 1) . The PE family of proteins contain a conserved amino-terminal region of about 110 amino acids. The carboxyl termini of this family are variable and fall into several classes. The largest class of PE proteins is the highly repetitive PGRS class which has a high glycine content. This PGRS domain is found to have sequences of glycine and alanine residues such as GGAGGX (where X is any amino acid), which can be repeated more than 30 times.
PPE family:
This family is named after a PPE (Pro-Pro-Glu) motif near the amino terminus of the domain (pfam00823) (Fig. 1) . The PPE proteins contain a conserved aminoterminal region of about 180 amino acids. The carboxyl terminus of this family is variable, and on the basis of this region are further subdivided based on their C terminal domain. PPE-SVP subgroup has a Gly-X-X-SerVal-Pro-X-X-Trp motif. The major polymorphic tandem repeat (MPTR) subgroup has multiple C terminal repeats of Asn-X-Gly-X-Gly-Asn-X-Gly. The third subfamily PPE-PPW consists of highly conserved Gly-Phe-X-GlyThr and Pro-X-X-Pro-X-X-Trp, C terminal motifs. The fouth subfamily members do not have homology at their C termini.
PE-PPE domain (pfam08237):
This domain refers to the variable domain found C terminal to PE and PPE motifs. The secondary structure of this domain is predicted to be a mixture of alpha helices and beta strands.
• A large-scale gene expression study indicates that these multiple PE and PPE genes exhibit a dynamic, differential and independent mode of expression rather than by a global co-regulation mechanism. This has been borne out by comparing the expression of 128 genes in 15 major growth conditions that include a range of stress conditions such as low pH, hypoxia, high temperature, denaturants, starvation, stationary phase, peroxide, drug treatment, etc., using a microarray hybridization format [49] .
• Specifi c expression of certain PE family genes suggests their possible role in pathogenesis or in virulence [50] . In a recent study, a similar profi le of expression was observed in different host tissue by using a RT PCR approach with three PE-PGRS genes [51] .
• DNA vaccine studies in mice showed that the PE domain PE-PGRS33 gene (Rv1818c) could induce a cellular immune response, whereas the whole PE-PGRS domain elicited a humoral immune response, diminishing the protective immune response of the host to the PE domain in the context of the PGRS region. Likewise, in a DNA vaccine based on the M. tuberculosis PE-PGRS33 gene (Rv1818c), the PGRS domain with 21 GGAGGX repeats, inhibited the host immune response to the adjacent PE domain [52] .
Mce
One or more 'mammalian cell entry' mce genes have been discovered in mycobacterial genomes. A typical mce gene is made of two domains, mce and Ttg, the former enabling cell entry, and the latter serving as a transporter as depicted and annotated below from the Conserved Domain database (Fig. 2) . 'The archetype mce domain in Rv0169 was isolated as being necessary for colonization of, and survival within, the macrophage. This mce protein family contains proteins of unknown function from other bacteria'.
'The Ttg2C (COG1463) domain is defi ned as ABC-type transport system involved in resistance to organic solvents, periplasmic component [Secondary metabolites biosynthesis, transport, and catabolism]'.
Several mce genes are found in tandem within a mce operon. Moreover, multiple partial or intact mce operons are variably distributed across pathogenic and non-pathogenic mycobacteria. The contributions of individual mce genes and the operons in the natural physiology of the bacteria have been diffi cult to assess. Establishing different in vitro culture conditions to represent active and stationary phase, Kumar et al. [53] have shown that genes within mce operons 1-4 are expressed in stationary phase (such as in standing cultures), while one or more mce genes are expressed during active growth. Only mce1 and mce4 of M. tuberculosis have been deemed essential for survival [31] . Kumar et al. [53] proposed that the biological functions and evolution of these clusters indicate a fundamental role in transport (for nutrients, metabolites, and extrusion of toxic molecules in saprophytic organisms via the Ttg2C domain), which have then been adapted for cell entry functions by pathogenic bacteria via the mce domain. The pair of genes encoding these proteins are located within a cluster know as the esx-1 locus, which potentially encodes a complex of multiple proteins forming a novel transport system worthy of a separate systematic nomenclature, i.e. Type VII secretory system [54] . Similar to the mce locus, genome duplication events indicate that there is a scattered distribution of multiple esx loci in pathogenic and non-pathogenic mycobacteria and other gram-positive species. There appears to be an inter-dependence between esx loci for secretion of the ESAT-6-CFP-10 and other proteins, but questions concerning the actual in vivo susbtrates that are secreted, and the details about shared functionalities and protein-protein interactions between the proteins within and between different esx loci remain [55] . It is also argued that ESAT-6, CFP-10 homologs, and other proteins, may be structural components of the transport machinery, rather than the natural substrates and actual effectors of virulence in pathogenic species. The esx loci include members of the PE-PPE family. Gey Van Pittius et al. [56] have postulated that from this original location, extensive gene duplication resulted in non esx locus distribution of PE-PPE genes in pathogenic bacteria.
Defi ning M. tuberculosis
Virulence factors discovered by genetic engineering As described earlier, genetic engineering and array technologies have aided in the search for virulence factors, i.e. proteins/pathways in processes such as attachment, infection, survival, persistence and reactivation. The M. tuberculosis loci that have emerged in independent experimental and in silico studies are: [61] Of these, as described earlier, the presence of one or more copies of the esx, mce and PE-PPE genes is a feature shared by pathogenic mycobacteria. M. avium subsp. avium and M. avium subsp. paratuberculosis are endowed with glycopeptidolipids (GPLs) instead of PDIMs.
• An innovative example of comparative genomics for functional validation is the discovery of the role for one of the four mce loci (mce4) in cholesterol catabolism and for survival of M. tuberculosis in macrophages [62] . This association was uncovered by using the soil actinomycete Multiple studies have investigated genes involved in signaling, DNA replication, DNA repair, cell division, secretion and transport of proteins and small molecules, and nutrition based on phenotypes of reference strains and their respective gene knock outs in animal models (beyond the scope of this review). Based on such approaches, a number of vaccine strains, drug targets and diagnostic reagents have been proposed, although only few of these research fi ndings have been tested for clinically applicable products.
Genetics of natural populations of M. tuberculosis
Although 'essential' and 'virulence' genes are often identifi ed through various experimental animal models using reference strains, it is of interest to verify if these fi ndings are relevant to clinical strains and well defi ned study populations.
• The work of Maeda et al. [63] and Tsolaki et al. [64] attempted to study the genomes of clinical isolates (in an array hybridization format) and to relate the genotypes to transmission phenotypes. They included strains with well characterized clinical and epidemiological datasets. The Maeda et al.
[63] study includes 13 representative clones from a larger collection (taken from 1744 patients studied in San Francisco during a seven year period in the 1990s that were responsible for 148 TB cases and Interestingly, several of the M. tuberculosis unique genes we listed in Table 4 were found to be deleted from some clinical strains (such as dehydrogenases, phospholipases, phage proteins). One or more genes within a large cluster (Rv1500-Rv1527c) that contains glycosyltransferases are deleted in some of these clones. The biological role of this cluster has not been described thus far, but may correspond in part to the lipooligosaccharide (LOS) biosynthetic locus in M. marinum [65] . A deletion of pks5 (Rv1527c) in H37Rv strain however diminishes, but does not abrogate virulence or persistence in mice [66] . LOSs are considered to be 'avirulence' factors absent in most clinical strains of M. tuberculosis. From the above San Francisco M. tuberculosis strain bank, Tsolaki et al. [64] further studied 100 strains to look for lineage specifi c and non-lineage specifi c genetic variations (50 that were involved in transmission clusters, and 50 that were unique or non-clustered). They identifi ed ~250 regions of difference (RD) [64] . Theoretically, these 'RD' genes are non-essential for human disease, or may have altered levels of virulence and host specifi city. Alternatively, by examining the RDs, it was postulated that dumping extra copies of mobile elements and lipoproteins reduces genomic and antigenic load (or immune evasion). Interesting was the fi nding of deletions of katG and furA, offering a possible antibiotic resistance mechanism; and that of genes within 'hypoxia' regulons conducive to the escape from latency, a means of promoting transmission. These events were considered to be 'positively selected' in phylogenetically unrelated isolates within vulnerable regions of the genome, while certain other genes were deleted in specifi c lineages only. Overall, the authors noted that the degree of LSPs was limited and not expected to exceed ~100 genes in M. tuberculosis isolates (5.5% of total genes), while in H. pylori, 22% genes can be deleted in a small sample set.
• Fleischmann et al. [67] took advantage of the complete genome sequences of M. tuberculosis strains CDC1551 and H37Rv and identifi ed SNP and LSPs (greater than 10 bp in this study). From this panel of genomic markers, a few were selected for interrogating polymorphisms in 169 epidemiologically characterized clinical isolates. In this and a subsequent study, it was found that LSPs can occur multiple times, and as independent events, fl anking IS6110 sequences being one the factors. One of these LSP groups (LSP A) comprising four loci was judged to be suitable for phylogenetic interpreations, while other LSPs occurred in regions subject to selection (rich in PE and PPE genes). Association of genotype to phenotype was indicated for deletion in plcD [68] ; extrapulmonary TB was two fold more likely with plcD mutant strains [69] .
• Noting that M. tuberculosis strains from Beijing, China are more closely related to each other, Van Soolingen et al. fi rst described the Beijing strains of M. tuberculosis [70] . These strains have similar IS6110 DNA containing restriction fragments. DNA polymorphisms within other repetitive DNA elements, such as the PGRS domains of PE-PPE genes and within the direct repeat (DR) used for a strain typing method known as spoligotyping is very limited.
The Beijing strains of M. tuberculosis are thought to be highly pathogenic strains since they acquire drug resistance [71] . They are thought to have emerged from China where BCG vaccination has been implemented for almost two decades and that this vaccination favored their selection, resisting BCG-induced immunity [72] . Beijing strains are also found to demonstrate distinct expression patterns of proteins; several species of α-crystallin (a known M. tuberculosis virulence factor) are enhanced, while there is decreased expression of heat shock protein of 65 kDa and many others [72] . In addition, the Beijing family strains produce high levels of phenolic glycolipid (PGL-tb), not made by H37Rv. These altered expression of proteins and glycolipids are thought to contribute to the success of the Beijing family strains. The Beijing/W strains have three times the propensity of non-Beijing strains to be associated with extrathoracic TB [74] .
• Dormans et al. [75] performed a comparative study of the phenotypes associated with nine different global major genotypes based on intratracheal mouse infection (progressive pulmonary tuberculosis model). They used a semi-quantitative scoring system to measure various parameters including histopathology of lung, bacillary load, survival and delayed type hypersensitivity. The genotypes could be broadly divided into three groups with low, moderate and high levels of virulence which correlated well with severity of histopathology and increased bacillary counts and reduced survival time. However the virulent strains also elicited the highest levels of DTH reactivity indicating a lack of correlation between DTH and protection. In general, the Beijing type and Africa strains were more virulent than the Amsterdam and Haarlem strains, while the H37Rv and Canetti strains were the least virulent in this study.
More studies that examine clinical isolates are needed for better evaluation of genotypes and gene functions in disease and immunity and to examine if there are interactions between host and bacteria when studied in different populations. Genetic markers, platforms for inexpensive and high throughput genome comparisons are thus warranted to extrapolate and validate the information that is generated from reference strains as they affect the development and effi cacy of diagnostics, vaccines and drugs. Our COG abundance screening has identifi ed a list of additional genes present in M. tuberculosis but not in other members of the test panel (Table 4 ). These include extra copies for a given function as for the phospholipase, phage proteins, and a few genes (Rv1514 and Rv1518) within a larger cluster of shared genes that are proximal to those involved in LOS in C. glutamicum. Genes within-frame mutation resulting in split genes and/or pseudogenes account for a few in this list. In summary (excluding the larger PPE, polyketide synthases and FAD/FMN dehydrogenase COGs), 26 genes were found only in M. tuberculosis, only one of these is deemed 'essential' [30] ; deletion mutants have been detected in clinical strains for nine. Therefore, these 26 genes in themselves may not solely defi ne the M. tuberculosis phenotype, but their presence or absence, individually or in combination with other genes may contribute to specifi c experimental and/or clinical states.
Defi ning and differentiating Mycobacterium avium subsp.
With regard to M. avium, collectively known as the M. avium complex (MAC), researchers are seeking better species defi nitions and nomenclature to enable rationale approaches for identifying source and modes of transmission of human and animal diseases and developing diagnostics and vaccines. Considering that MAC organisms are found to reside in both environmental and host associated niches, Turenne et al. [76] have recommended that MAC be considered as a 'microcosm' of mycobacteria with distinct genomic identities. It is expected that additional sequencing of representative genomes from different host niches will clarify some of the existing confusion in taxonomy.
Three subsets of M. avium, obtained from non-human sources have been defi ned according to DNA-DNA hybridization and phenotypic properties (growth and biochemical tests); M. avium subsp. avium, M. avium subsp. paratuberculosis and M. avium subsp. silvaticum. Although M. intracellulare is given a species status and is found more often in immune competent hosts as opposed to the M. avium subsets associated with immune-defi cient patients, it is placed within MAC, and controlled with therapeutic regimens common to M. avium subsp. MAC now also includes M. avium subsp. hominissuis of which the reference strain no. 104 has been sequenced. The M. avium subsp. hominissuis differs from M. avium sp. by the presence of multiple copies of IS1245 insertion sequence, variable 16S-23S internal transcribed spacer, tolerance to a wide temperature range and the lack of IS901 sequences. M. lepraemurium is related to MACs by DNA-DNA hybridization, and in 16S rRNA sequence, but not by hsp65 sequence; it is not placed in MAC. Apparently M. avium subsp. silvaticum is hardly distinguishable from M. avium subsp. avium and doesn't warrant a subspecies classifi cation.
• Turenne et al. [76] have pointed out that although M. avium subsp. avium are popularly referred to as environmental species, strains found in birds are not found in human MAC infections and environmental sources [71] . On the other hand the M. avium subsp. hominissuis is found in multiple sources and more likely represents an environmental species.
Due to these confounding observations, studies in MAC have often dealt with diagnostic issues and developing molecular diagnostic probes has been a major thrust for clinical and fi eld applications. In addition, genomes have been queried to search for genes responsible for host and tissue specifi city and the differences in growth rates and specifi c requirements in in vitro culture. (Table 5) . Overall, these two species contain COGs as seen in 'environmental' and non-pathogens such as M. smegmatis and Mycobacterium 
Defi ning Mycobacterium ulcerans Agy99
After TB and leprosy, Buruli ulcer, well known in parts of Australia and Papaua New Guinea is emerging as a serious disease in Africa. Therefore efforts to study the causative mycobacteria, M. ulcerans, have lead to deciphering its genome sequence, confi rming a phylogenetic descent from that of M. marinum, a pathogen in ectotherms such as frogs and fi sh. M. ulcerans shows features of gene reduction, restricted host range and niche, and dependence on host for growth reminiscent of M. leprae [5] , M. avium subsp. paratuberculosis [7] , and other recently evolved bacteria (Yersinia pestis [80] , Burkholderia mallei [81] Table 6 ). A key genomic feature is the acquisition of a plasmid encoding mycolactone, an immunosuppressive cytotoxin macrolide [6] . Also, the glycosylation machinery for generating phenolic glycolipids is lost.
The composition, glycosyl linkages and methyl modifications of phenolic glycolipids are species specifi c and also antigenic (Table 7) and details can be found in a review by Onwueme et al. [57] and references therein.
The genetic locus involved in the attachment and methylation of the glycosyl residues at the phenol moiety of PGL-Tb of M. tuberculosis has been verifi ed [82, 83] . The comparison of this locus in the sequenced strain of M. ulcerans and M. marinum and M. leprae is shown in Fig. 4 verifying that the gene for the fi rst glycosylation step is defective, while the genes for the other two glycosyltransferases and methyltransferases are absent. In M. marinum however, consistent with the published structure of phenolic glycolipid [6] , there is only one gene for the fi rst glycosylation reaction and none for methylation. Also, with regard to the diol lipid backbone, while M. tuberculosis, M. marinum and M. leprae have a ketoreductase to convert a pthidiodolone to phthiocerol, this gene is a pseudogene in M. ulcerans.
The native PGL-I of M. leprae or its synthetic glycoconjugate antigen have been used extensively in serological investigations to aid as a tool to detect leprosy infection [84] . Thus far, there has been only one publication regarding cross reactivity of PGL-1 antibodies reactivity to M. ulcerans [85] . This and a prior study with references to glycosylated PGL versions in M. ulcerans [86] are not compatible with the current genome information. Therefore, strain variants may reconcile these issues of the presence of phenolic glycolipids in M. ulcerans [86, 87] .
Defi ning Mycobacterium leprae TN
Since the M. leprae TN genome was placed in public domain in 2001 [5] , and the fi rst annotated version was accessible through the Leproma website, we and others have commented on the genome content of M. leprae [5, 42, 88, 89] .
It was anticipated that the genome knowledge will solve challenging questions of in vitro growth, and identify virulence factors and explain pathogenesis including nerve damage [5] . The severe gene loss that has left a small repertoire of ~1600 genes explains intracellularism, but there doesn't appear to be any signifi cant new knowledge thus far from the "M. leprae" unique genes that can account for its pathology and tissue specifi city. In order to gain insight into the peculiar growth properties and adaptations of M. leprae, it may be of interest to pay attention to genes not necessarily shared with M. tuberculosis, but also those that are present in other species as listed in Table 9 . The origin and distribution pattern of these genes is interesting, and tests of functionality can be pursued in one of the tractable species such as C. glutamicum and M. smegmatis.
The genome has provided some clues for modifi cation of the growth conditions in vitro, however: applying and testing these in practice remains a daunting proposition (http: //igs-server.cnrs-mrs.fr/axenic-cgi/generate_table?Mycoba cterium+no+off+off ), particularly due to the long doubling time (~ 2 weeks). The doubling time of M. ulcerans in vitro, was reduced by the addition of algal extracts in the growth media; a phenotype such as this would be a boost for the study of M. leprae in the laboratory.
In this review, we corroborate previous hypotheses that the 'mycobacterial cell wall core' biosynthetic machinery is intact per in silico evidence and furthermore we update gene lists for biosynthesis of known cell wall and associated macromolecule biosynthesis and their occurrence in mycobacteria including M. leprae (Table 8) . Within Table 8 , there are numerous examples of how the elucidation of gene function (as applied in other mycobacterial and related species) has been possible by a process of candidate gene selection via careful homology and domain searches followed by experimental "wreck and check" methodologies.
• The search for diagnostic reagents from genome based approaches has been pursued with M. leprae specifi city as an important criterion [170, 171, 172] . The work of Duthie et al. [173] , focused on the search for potential serologically reactive protein antigens prior to testing for the rigorous requirement for leprosy specifi city when tested in various endemic populations. Such approaches lead to the identifi cation of new antigens (ML0405, ML 2331) from which novel fusion proteins were designed. While sequence similarity with counterparts in other species is restricted to M. tuberculosis and M. bovis for ML0405, it extends to M. avium, M. smegmatis and M. marinum for ML2331. In this regard, other candidate gene lists have been put forth, including genes with occurrences in more than one sequenced mycobacetria [92] .
• Regarding the evolution and origin of M. leprae, Gomez-Valero et al. [43] speculate that M. leprae is more closely related to M. tuberculosis than to M. avium (the analysis was based on M. avium subsp. paratuberculosis). They propose that a series of gene by gene inactivation events rather than loss of 'blocks of genes' lead to pseudogenes followed by a gradual loss of nucleotides in M. leprae and that these processes started after the M. avium-M. tuberculosis branch split. They note that the majority of the original sequence (~89%) persists in pseudogenes in the extant genome. By identifying orthologs and gene order they reconstruct the genome of the last common ancestor of M. tuberculosis and M. leprae. strain has been a model organism exploited extensively for mycobacteria research. Its sequence is larger than M. tuberculosis with nearly twice the coding potential. There are many COGs of higher and lower abundance in this species compared to the pathogenic species as depicted in Table 3 and Fig. 3 . The relative distribution of the genes assigned to COGs in M. smegmatis and M. tuberculosis is highlighted in Fig. 5 . COGs involved in transport and metabolism of amino acids, carbohydrates, inorganic ions, lipids and secondary metabolites are larger in M. smegmatis compared to M. tuberculosis. There are additional genes attributed to energy production, and transcription, and those without any specifi c functional prediction. Together these expanded COGs account for the additional 2402 genes in M. smegmatis, compared to M. tuberculosis. On the other hand, despite, the lager genome size, the number of genes for certain pathways and functionalities are not enriched or redundant. This type of comparison indicates that there are pathways that can be maintained by a basic minimum number of genes in most mycobacteria.
Defi ning
We found that M. smegmatis, M. avium. subsp. avium and paratuberculosis share a single gene assigned to the COG category 'chromatin structure and dynamics' and an additional gene for RNA processing and modifi cation (Table 3 ).
• Recently, a comprehensive genome based study by Titgemeyer et al. predicts and validates genes involved in sugar transport in M. smegmatis and M. tuberculosis [174] . The distinct excess of carbohydrate uptake systems in M. smegmatis (28) over that in M. tuberculosis (5), refl ect saprophytic versus host dependent pathogenic lifestyles.
Conclusions and perspectives
Delving into the genomes of mycobacterial and related species has furthered our knowledge of genes associated with common and unique growth requirements, habitats, and cell wall molecules, all applicable; important pathogenic and model microbes which have been applied towards targeted approaches for controlling mycobacterial diseases via vaccines and antimicrobials. In addition, the DNA sequences has allowed for selection of appropriate probes for diagnosis, strain typing, and reconstruction of evolutionary schemes. During the preparation of this article, a comprehensive review of actinobacteria from a genomics perspective has been published [175] . The basis of pathogenicity of mycobacteria is thought to depend completely or in part on members of expanded gene families such as esx, PE-PPE, pks, mce etc. The COG abundance profi les comparisons demonstrate these genes and others that are common or enriched in the three pathogenic species relative to the non-pathogenic species (E. coli, M. avium subsp. avium, C. glutamicum). Nonpathogenic species also have orthologs for one or more of these genes, suggesting functions common to metabolism or biosynthesis of macromolecules. However, we found that the majority of the M. tuberculosis restricted genes are deemed 'non-essential' in experimental models. It is therefore clear that redundant genes (arising from gene duplication events) preclude the precise functional assignment of individual genes, particularly within the large families. Therefore, differential expression and complex genetic interactions are likely to infl uence pathogenicity and fi tness of individual mycobacterial species within changing host milieus.
Further studies of natural populations, particularly of clinical isolates in conjunction with epidemiology are important for a comprehensive understanding of mycobacteria and the nuances of host-bacteria interactions in their native environments and in disease. Though much emphasis is still currently placed on individual open reading frames, the future of genomics, supported by other 'omics' may allow for such comprehensive studies in the coming years. In parallel, it is envisioned that bioinformatics will keep pace with the large amount of data (raw genome sequence and metadata) to allow informed gene function predictions requiring minimal laboratory testing and become accessible to the average microbiologist lacking formal training in bioinformatics/computational skills. disruption of a mas-like gene or a chalcone synthase-like
